ANDREA RITA HORVATH, MD, PhD, FRCPath(UK), FRCPA
is Director of Chemical Pathology in New South Wales Health Pathology at the Prince of Wales Hospital in Sydney, Australia. She is conjoint professor of the University of New South Wales, honorary professor of the University of Sydney and a visiting fellow at Macquarie University. Her key research interest and passion is evidence-based laboratory medicine (EBLM), evidence-based evaluation of biomarkers and effectiveness and safety of laboratory testing.
She had multiple national and international leadership roles: President of the Hungarian Society of Laboratory Medicine, Secretary of European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4); President of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM); Member of the Board of Directors of the American Association of Clinical Chemistry (AACC). For 6 years (2003-2008) she chaired the Committee on EBLM in the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and she was vice chair of the EBLM Committee of AACC for 8 years (2012-2020). She was the founder and past chair of the Test Evaluation Working Group of EFLM. Currently she chairs an EFLM Task Group on Outcome-Based Analytical Performance Specifications for Tests.
She was one of the three senior editors of the 6th edition of the Tietz Textbook and the 8th edition of the Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics. She held the 20th and 10th
position on The Pathologist’s Power List of the 100 Most Influential Pathology Professionals in 2015 and 2018, respectively.
|